Rchr
J-GLOBAL ID：202201007095223210   Update date: Feb. 01, 2024

Yamazaki Kana

ヤマザキ カナ | Yamazaki Kana
Affiliation and department：
National Institutes for Quantum and Radiological Science and Technology Institute for Quantum Medical Science, Department of Molecular Imaging and Theranostics

About National Institutes for Quantum and Radiological Science and Technology Institute for Quantum Medical Science, Department of Molecular Imaging and Theranostics


Job title： Senior Resercher
Research theme for competitive and other funds  (1)：
  • 2021 - 2025 新規アミノ酸PETプローブによる早期膵癌画像診断法の開発
Papers (11)：
  • Yuka Muranaka, Miki Matsue, Asuka Mizutani, Masato Kobayashi, Kakeru Sato, Ami Kondo, Yuri Nishiyama, Shusei Ohata, Kodai Nishi, Kana Yamazaki, et al. Evaluation of L-Alanine Metabolism in Bacteria and Whole-Body Distribution with Bacterial Infection Model Mice. International Journal of Molecular Sciences. 2023. 24. 5. 4775-4775
  • Kakeru Sato, Asuka Mizutani, Yuka Muranaka, Jianwei Yao, Masato Kobayashi, Kana Yamazaki, Ryuichi Nishii, Kodai Nishi, Takeo Nakanishi, Ikumi Tamai, et al. Biological Distribution after Oral Administration of Radioiodine-Labeled Acetaminophen to Estimate Gastrointestinal Absorption Function via OATPs, OATs, and/or MRPs. Pharmaceutics. 2023. 15. 2. 497
  • Kana Yamazaki, Ryuichi Nishii, Yoichi Mizutani, Hirokazu Makishima, Takashi Kaneko, Yoshiharu Isobe, Tamasa Terada, Kentaro Tamura, Etsuko Imabayashi, Toshiaki Tani, et al. Estimation of post-therapeutic liver reserve capacity using 99mTc-GSA scintigraphy prior to carbon-ion radiotherapy for liver tumors. European journal of nuclear medicine and molecular imaging. 2022. 50. 2. 581-592
  • Kazuo Narushima, Ryuichi Nishii, Shinichi Okazumi, Hideaki Shimada, Yasunori Akutsu, Takamasa Maeda, Shigeo Yasuda, Shigeru Yamada, Kiyohiko Shuto, Kentaro Tamura, et al. [S-methyl-11C]-L-methionine positron emission tomography/computed tomography imaging parameters to evaluate early response for esophageal cancer with neoadjuvant carbon ion radiotherapy. Scientific reports. 2022. 12. 1. 13694-13694
  • Yuka Muranaka, Asuka Mizutani, Masato Kobayashi, Koya Nakamoto, Miki Matsue, Fumika Takagi, Kenichi Okazaki, Kodai Nishi, Kana Yamazaki, Ryuichi Nishii, et al. 123I-BMIPP, a Radiopharmaceutical for Myocardial Fatty Acid Metabolism Scintigraphy, Could Be Utilized in Bacterial Infection Imaging. Pharmaceutics. 2022. 14. 5
ｍore...
MISC (4)：
  • 山崎 香奈, 西井 龍一, 前田 貴雅, 田村 謙太郎, 牧島 弘和, 粕谷 吾朗, 張 大鎮, 吉永 恵一郎, 東 達也, 辻 比呂志. 123I-IMP SPECT 6時間後撮像による脈絡膜悪性黒色腫の半定量的評価. 核医学. 2020. 57. 1. 36-36
  • 山崎 香奈, 西井 龍一, 牧島 弘和, 粕谷 吾朗, 張 大鎮, 村上 康二, 田村 謙太郎, 吉永 恵一郎, 東 達也, 辻 比呂志. 2相SUV値を用いた123I-IMP SPECTによる脈絡膜悪性黒色腫の半定量的評価. 核医学. 2019. 56. Suppl. S160-S160
  • 山崎 香奈, 西井 龍一, 吉永 恵一郎, 粕谷 吾郎, 牧島 弘和, 辻 比呂志, 東 達也. 99mTc-MAG3レノグラムを用いた腎細胞癌重粒子線治療前後の腎機能評価. 核医学. 2019. 56. 1. 37-37
  • 山崎 香奈, 西井 龍一, 吉永 恵一郎, 粕谷 吾朗, 牧島 弘和, 辻 比呂志, 東 達也. 腎細胞癌に対する重粒子線治療における99mTc-MAG3レノグラム検査の有用性. 核医学. 2018. 55. Suppl. S165-S165
Patents (2)：
  • 標識化合物、及びその利用
  • 標識化合物、及びその利用
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM